Home › Therapeutic areas › Oncology › Lung Cancer
Lung Cancer (2 companies)
Companies with an active program in Lung Cancer.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| BCTX | BriaCell Therapeutics | Oncology | 1 | Phase 3 | $34.5M | 8 |
| IMCR | Immunocore | DermatologyInfectious Disease+2 | 1 | Approved | $1.60B | 15 |
No companies match.